The overall purpose of the Survey Research Core (SRC) is to provide standardized services for conducting survey-based research. The SR(5 collects and manages survey-based research data for population-based studies. SRC utilizes a critical mass of highly trained personnel to maximize efficiency, reduce the cost and optimize participation rates from survey-based research. The Core services include: i) sample selection;ii) survey design and pre-testing;iii) implementing and monitoring mailed surveys;iv) conducting all aspects of telephone survey;v) implementation of all aspects of web-based survey;vi) tracking study subjects lost to follow-up;and vii) automated data entry. The SRC is located in the Department of Population Sciences that houses the vast majority of the Cancer Control and Population Sciences (CCPS) members. While the SRC serves primarily the members of the CCPS Program, it has also provided services to members of the Hematological Malignancies, and Developmental Cancer Therapeutics Programs interested in conducting research utilizing mailed, web-based, or telephone surveys for collecting exposure or outcome data. Dr. Can- Lan Sun has directed the Core since its inception in 2006. The staff of the SRC includes one Clinical Research Associate, and one MS-prepared Biostatistician, with close collaboration with and supervision by the Ph.D.-level Biostatistician. In order to handling mass mailing surveys and collecting high-quality data, the SRC utilizes Cardiff Teleform Information Capture System, an automated content capture system, and the DatStat Illume integrated platform to conduct web-based surveys. Since December 2007, SRC services have been utilized by 40 studies, resulting in the development of over 150 forms. The vast majority of the core's time has been spent on scannable form design/on-line survey design, scanning/ verification and database management Services provided by the SRC have resulted in several high impact publications.

Public Health Relevance

The overall goal of the Survey Research core facility is to conduct survey-based research to obtain data for population-based studies. The facility uses highly trained personnel and assist in sample selection, survey design, conduct surveys via phone and web, track study subjects for follow-up and develop automated data entry. This goal enhances the Cancer Center's dedication to developing innovative new disease-fighting strategies in the battle against cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA033572-30
Application #
8450543
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-08-01
Project End
2017-11-30
Budget Start
2013-04-25
Budget End
2013-11-30
Support Year
30
Fiscal Year
2013
Total Cost
$50,490
Indirect Cost
$20,436
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Gast, Charles E; Silk, Alain D; Zarour, Luai et al. (2018) Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv 4:eaat7828
Salgia, Ravi; Kulkarni, Prakash (2018) The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer. Trends Cancer 4:110-118
Yoon, Sorah; Wu, Xiwei; Armstrong, Brian et al. (2018) An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFR? Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma. Mol Ther Nucleic Acids 14:131-141
Yim, John H; Choi, Audrey H; Li, Arthur X et al. (2018) Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule Diagnostics. Clin Cancer Res :
Wang, Tianyi; Fahrmann, Johannes Francois; Lee, Heehyoung et al. (2018) JAK/STAT3-Regulated Fatty Acid ?-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance. Cell Metab 27:136-150.e5
Magilnick, Nathaniel; Boldin, Mark P (2018) Molecular Moirai: Long Noncoding RNA Mediators of HSC Fate. Curr Stem Cell Rep 4:158-165
Yun, Xinwei; Zhang, Keqiang; Wang, Jinhui et al. (2018) Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma. Mol Cancer Res 16:1161-1171
Herrera, Alex F; Rodig, Scott J; Song, Joo Y et al. (2018) Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma. Biol Blood Marrow Transplant 24:514-520
Slavin, Thomas P; Banks, Kimberly C; Chudova, Darya et al. (2018) Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing. J Clin Oncol :JCO1800328
Shahin, Sophia A; Wang, Ruining; Simargi, Shirleen I et al. (2018) Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer. Nanomedicine 14:1381-1394

Showing the most recent 10 out of 1396 publications